Thomas D. Salus - Apr 14, 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Legal & Administration
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for Thomas D Salus
Stock symbol
LFCR
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/16/2025, 04:38 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +45K 45K Apr 14, 2025 Direct F1
transaction LFCR Common Stock Award +170K +377.78% 215K Apr 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Performance-Based Restricted Stock Units Award $0 +370K $0.00 0 Apr 14, 2025 Common Stock 370K Direct F2, F3, F4
transaction LFCR Incentive Stock Option (Right to Buy) Award $0 +210K $0.00 210K Apr 14, 2025 Common Stock 210K $6.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
F4 The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock prices.